Skip to content
2000
Volume 17, Issue 8
  • ISSN: 1574-888X
  • E-ISSN: 2212-3946

Abstract

Wilson Disease (WD) is a copper excretion disorder, mainly caused by mutations in the ATP7B gene. Pharmacological therapies and liver transplantation are currently the main treatment methods for WD, but they face problems such as drug treatment compliance, adverse reactions, and shortage of liver donors. Stem cell therapy of WD may correct abnormal copper metabolism permanently, which is the focus of current research. In this review, we summarized the latest research on stem cells treatment for WD, as well as current challenges and future expectations.

Loading

Article metrics loading...

/content/journals/cscr/10.2174/1574888X16666211006111556
2022-11-01
2025-05-19
Loading full text...

Full text loading...

/content/journals/cscr/10.2174/1574888X16666211006111556
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test